Literature DB >> 15929195

Manipulation of enteric flora in ulcerative colitis.

Mario Guslandi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15929195      PMCID： PMC4316076          DOI： 10.3748/wjg.v11.i21.3327

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  7 in total

1.  Probiotics for chronic intestinal disorders.

Authors:  Mario Guslandi
Journal:  Am J Gastroenterol       Date:  2003-03       Impact factor: 10.864

Review 2.  Drug therapy for ulcerative colitis.

Authors:  Chang-Tai Xu; Shu-Yong Meng; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

Review 3.  Antibiotics for inflammatory bowel disease: do they work?

Authors:  Mario Guslandi
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-02       Impact factor: 2.566

4.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

5.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

6.  A pilot trial of Saccharomyces boulardii in ulcerative colitis.

Authors:  Mario Guslandi; Patrizia Giollo; Pier Alberto Testoni
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-06       Impact factor: 2.566

7.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.